Feb 7 (Reuters) - VBI Vaccines Inc VBIV.O -
* Receives positive EMA scientific advice regarding Sci-B-Vac(TM) Phase III clinical study
* Evaluating plans for pivotal phase III clinical studies with U.S. Food and Drug Administration (FDA) and Health Canada Source text for Eikon: ID:nCCN5FTyqf Further company coverage: VBIV.O